Gustavo Monnerat, Deputy Editor at The Lancet, shared a post on LinkedIn:
“Largest study of breast cancer burden just published in The Lancet Oncology, covering 204 countries from 1990 to 2023 with forecasts to 2050.
Key findings from GBD 2023:
- 2.30 million new cases, 764,000 deaths, and 24.1 million DALYs among women globally in 2023. By 2050, cases are projected to reach 3.56 million with 1.37 million deaths.
- In low-income countries, age-standardised incidence surged 147.2% since 1990 versus just 1.2% in high-income countries.
- Risk factors including dietary risks, tobacco, and high fasting plasma glucose accounted for 28.3% of breast cancer DALYs in 2023.
These numbers demand urgent action on early detection and treatment access, though sparse registry data in these settings means the true burden may vary.
GBD 2023 Breast Cancer Collaborators. Global, regional, and national burden of breast cancer among females, 1990–2023, with forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2023 . Lancet Oncol 2026.”
